The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of CapeOX plus bevacizumab therapy with a planned oxaliplatin stop-and-go strategy in patients with metastatic colorectal cancer: A multi-center, single-arm, phase II study (CCOG-0902 study).
 
Yuuki Sunakawa
No Relationships to Disclose
 
Goro Nakayama
No Relationships to Disclose
 
Kiyoshi Ishigure
No Relationships to Disclose
 
Hiroyuki Yokoyama
No Relationships to Disclose
 
Keisuke Uehara
No Relationships to Disclose
 
Mitsuro Kanda
No Relationships to Disclose
 
Kenta Murotani
No Relationships to Disclose
 
Tsutomu Fujii
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Ajinomoto; Asahi Kasei; Chugai Pharma; Covidien/Medtronic; Johnson & Johnson; Kaken Pharmaceutical; Lilly; Olympus; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - abbott Japan (Inst); Abbvie (Inst); Ajinomoto (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Covidien (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Japan Blood Products Organization (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); KCI (Inst); Lilly Japan (Inst); Maruho (Inst); Merck (Inst); Mitsubishi Tanabe Pharma (Inst); Nippon Kayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Teijin Pharma (Inst); Toyama Chemical Co (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst); Yoshindo (Inst)